4//SEC Filing
IMS Health Holdings, Inc. 4
Accession 0001595262-16-000063
CIK 0001595262operating
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:54 PM ET
Size
24.1 KB
Accession
0001595262-16-000063
Insider Transaction Report
Form 4
Bruehlman Ronald E
See Remarks
Transactions
- Disposition to Issuer
Common Stock
2016-10-03−148,483→ 0 total - Award
Common Stock
2016-10-03+35,828→ 148,483 total - Disposition to Issuer
Employees Stock Option (right to buy)
2016-10-03−60,000→ 0 totalExercise: $7.00From: 2013-07-16Exp: 2021-07-16→ Common Stock (60,000 underlying) - Disposition to Issuer
Stock Appreciation Right
2016-10-03−35,397→ 0 totalExercise: $25.02Exp: 2025-02-10→ Common Stock (35,397 underlying) - Disposition to Issuer
Stock Appreciation Right
2016-10-03−79,745→ 0 totalExercise: $23.00Exp: 2026-02-02→ Common Stock (79,745 underlying) - Disposition to Issuer
Employees Stock Option (right to buy)
2016-10-03−60,000→ 0 totalExercise: $11.20From: 2012-07-16Exp: 2021-07-16→ Common Stock (60,000 underlying) - Disposition to Issuer
Employees Stock Option (right to buy)
2016-10-03−230,000→ 0 totalExercise: $4.40From: 2016-07-16Exp: 2021-07-16→ Common Stock (230,000 underlying) - Disposition to Issuer
Stock Appreciation Right
2016-10-03−11,798→ 0 totalExercise: $25.02From: 2016-02-10Exp: 2025-02-10→ Common Stock (11,798 underlying) - Award
Common Stock
2016-10-03+20,935→ 112,655 total
Footnotes (12)
- [F1]On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
- [F10]This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 13,592 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
- [F11]This stock appreciation right vests in four annual installments beginning on February 2, 2017.
- [F12]This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 30,622 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share.
- [F2]On February 10, 2015 the reporting person was granted 17,563 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 20,935 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 8,039 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017
- [F3]On February 2, 2016, the reporting person was granted 26,019 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 35,828 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 13,757 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018.
- [F4]Disposed of pursuant to merger agreement in exchange for 57,017 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
- [F5]This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $29.17 per share.
- [F6]This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $18.23 per share.
- [F7]This option was assumed by Quintiles in the merger and replaced with an option to purchase 88,320 shares of Quintiles IMS Holdings, Inc. common stock at a price of $11.46 per share.
- [F8]This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 4,530 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
- [F9]This stock appreciation right vests in three annual installments beginning on February 10, 2017.
Documents
Issuer
IMS Health Holdings, Inc.
CIK 0001595262
Entity typeoperating
Related Parties
1- filerCIK 0001595262
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 6:54 PM ET
- Size
- 24.1 KB